NAMS (NewAmsterdam Pharma Corp) Wutah bathi ing taun lumaku

NAMS (NewAmsterdam Pharma Corp) - tandha merek perusahaan

The annual EPS growth rate demonstrates current dynamics, where 11.20 reflects the latest value of the metric. Currently, NewAmsterdam Pharma (NAMS) relies critically on the results of the final stage of tests for its primary cholesterol treatment. There is a possibility of more affordable alternatives emerging, which would create significant market barriers. However, success in metabolic therapy innovations will ensure a stable cash flow for years to come.

NAMS: Wutah bathi saben saham ing taun lumaku NewAmsterdam Pharma 21.06.2023 - 17.11.2026

Rincian metrik keuangan lan pasar NewAmsterdam Pharma Company (NAMS)

- rega saham lan prakiraan rega para ahli:
Analisis dhasar perusahaan:NAMS - NewAmsterdam Pharma Corp
Produk dadi NewAmsterdam Pharma Company N.V.

Investors must evaluate business resilience through net income per share dynamics, which measure the growth rate of real shareholder income relative to the previous year. By analyzing the annual EPS change ratio, one can confirm the commercialization efficiency of NewAmsterdam Pharma (NAMS) new lipid-lowering drugs, which replace traditional statins to reduce cardiac risks.

Pesaing utama

ASND: Wutah bathi resik saben siji saham kanggo taun lumaku|MDGL (Madrigal Corp) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Corcept Therapeutics|Wutah bathi ing taun lumaku RYTM|Wutah bathi saben saham ing taun lumaku AKRO (Akero Therapeutics, Inc.)|Wutah bathi saben saham ing taun lumaku metsera.com MTSR|MoonLake Corp (MLTX) - Kacepetan wutah bathi saben saham ing taun lumaku|CRNX - Wutah bathi saben saham ing taun lumaku|SLNO: Wutah bathi saben saham ing taun lumaku|FOLD: Wutah bathi ing taun lumaku|ETNB - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Agios Corp|Structure Corp (GPCR) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku mimedx.com (MDXG)|Wutah bathi resik saben saham ing taun iki rezolutebio.com RZLT|Wutah bathi saben saham ing taun lumaku Lexicon Pharmaceuticals, Inc. LXRX|MBX Bio - Wutah bathi saben saham ing taun lumaku|ALT: Wutah bathi resik saben saham ing taun iki|AARD - Wutah bathi ing taun lumaku|SGMT: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku BioAge Labs, Inc. (BIOA)|Wutah bathi saben saham ing taun lumaku Biomea Fusion Inc|Wutah bathi saben saham ing taun iki QNCX (Quince Therapeutics)|Wutah bathi resik saben saham ing taun iki GUTS (Fractyl Health)|Wutah bathi resik saben siji saham kanggo taun lumaku VTVT|Agape ATP Corporation - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku PLUR|Synlogic Inc. - Wutah bathi ing taun lumaku|LPCN (Lipocine) - Wutah bathi saben saham ing taun iki|MTNB (Matinas BioPharma Holdings Inc.) - Wutah bathi resik saben saham ing taun iki|SPRB (Spruce Biosciences, Inc.) - Wutah bathi saben saham ing taun lumaku|GLTO (galecto.com) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki carmellrx.com (CTCX)|Wutah bathi saben saham ing taun lumaku Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Tambahing bathi saben saham ing taun lumaku|radiuspharm.com - Wutah bathi resik saben saham ing taun iki